The novel approach of the medication represents a exciting development in the handling of type 2 diabetes. Different to existing medications, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide240646.yomoblog.com/49398462/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment